ABEO - Abeona Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,9988378891,040
Cost of Revenue38,69816,98910,655-
Gross Profit-35,700-16,152-9,7661,040
Operating Expenses
Research Development-16,98910,6554,715
Selling General and Administrative20,10610,94313,29014,320
Non Recurring----
Total Operating Expenses61,16428,67324,77019,586
Operating Income or Loss-58,166-27,836-23,881-18,546
Income from Continuing Operations
Total Other Income/Expenses Net1,4959643,8994,020
Earnings Before Interest and Taxes-58,166-27,836-23,881-18,546
Interest Expense-11-8-6-6
Income Before Tax-56,671-27,319-21,873-14,526
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-56,671-27,319-21,873-14,526
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-56,671-27,319-21,873-14,526
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-56,671-27,319-21,873-14,526